FIA586

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FIA586, covering 2024-06-20 to 2024-06-20. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics Study of FIA586 in Participants With Mild and Moderate Hepatic Impairment [Phase 1]